Arcutis Biotherapeutics, Inc. Share Price & Technical Analysis
ARQT · $21.25 (+1.87%)
Healthcare / Biotechnology
$21.25
+1.87%
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a pot…
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
-10% return in May, -19% avg return in past 3 year May month.
-26% return in 2026, 76% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -12% | 8% | -9% | -3% | -10% | – | – | – | – | – | – | – | -26% |
| 25 | -7% | 6% | 15% | -4% | -13% | 7% | 5% | 8% | 22% | 34% | 22% | -4% | 90% |
| 24 | 84% | 81% | -3% | -17% | 0% | 11% | 10% | 8% | -14% | -11% | 55% | 7% | 211% |
| 23 | 10% | -2% | -34% | 25% | -44% | 27% | 15% | -21% | -38% | -58% | -18% | 68% | -72% |
| 22 | -26% | 18% | 8% | 5% | 3% | 2% | 15% | 9% | -29% | -9% | -4% | -14% | -23% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$2.56B
P/E ratio
—
52W high
$31.77
52W low
$12.72
Volume
15,64,986
Beta
1.59
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Arcutis Biotherapeutics, Inc. share price today?
- Arcutis Biotherapeutics, Inc. (ARQT) last traded around $21.25 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ARQT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ARQT. Download the app for real-time alerts.
- How can I analyze Arcutis Biotherapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.